Dr. Tadashi YAMAMOTO Received Clinical and Translational Proteomics Award, HUPO 2020
January 19, 2021
Dr. Tadashi YAMAMOTO, the professor emeritus of the Biofluid Biomarker Center of Kidney Research Center, Graduate School of Medical and Dental Sciences, Niigata University, received "HUPO 2020 Clinical and Translational Proteomics Award", from Human Proteome Organization (HUPO).
HUPO is the international consortium, launched in 2001, with the aim of mapping the entire human protein set (proteome) after the completion of the human genome sequencing project.
This award is an annual award presented to the only one scientist around the world who conducts prominent proteomics research, contributing to clinical and translational research. Dr. YAMAMOTO was the first recipient of this award in Asia.
The award-winning achievement was highly regarded for the selection of urinary biomarkers for kidney disease by proteomics and its clinical application as well as for showing possibilities to develop into "All-in-One Urine Tests", urinalysis to realize early checkup of all diseases.
Related links:
Human Proteome Organization: 2020 HUPO Awards
Original website of Biofluid Biomarker Center (Japanese only)
More News
-
Mapping Potential Conflict Zones Between Offshore Wind Development and Little Terns Across Japan: A New Spatial Screening Framework to Support Environmental Impact Assessment
Research results
-
A New Clue for Assessing the Body’s Response to Mild Electrical Stimulation of the Ear: Changes in Heart Rate Regulation Observed in 17 of 18 Participants
Research results
-
Insertion or deletion variants in TAF15 exon 15 are genetic factors impacting the prognosis of amyotrophic lateral sclerosis in a Japanese cohort
Research results
-
Distinct recombinant tau fibril conformations induce divergent propagation and neurodegenerative phenotypes in a model mouse
Research results